Ständer, Sonja http://orcid.org/0000-0003-3612-7786
Luger, Thomas
Kim, Brian
Lerner, Ethan
Metz, Martin
Adiri, Roni
Canosa, Juliana M.
Cha, Amy
Yosipovitch, Gil
Funding for this research was provided by:
Pfizer Inc.
Article History
Received: 29 September 2023
Accepted: 5 December 2023
First Online: 6 January 2024
Declarations
:
: Roni Adiri, Juliana M. Canosa, and Amy Cha are employees and shareholders of Pfizer Inc. Ethan Lerner is a member of the Scientific Advisory Board for Escient Pharmaceuticals Inc. Martin Metz has received honoraria as a speaker and/or advisor for Pfizer Inc., AbbVie, Amgen, AstraZeneca, argenx, Bayer, Beiersdorf, Celldex, Escient, Galderma, GSK, Jasper, Novartis, Pharvaris, Sanofi-Aventis, Teva, ThirdHarmonicBio, and Vifor. Sonja Ständer was a speaker, consultant, and/or investigator and/or has received research funding from Pfizer Inc., AbbVie, Almirall, Beiersdorf, BMS, Clexio, Eli Lilly and Company, FomF, Galderma, German Research Foundation, Integrity CE, Kiniksa, LEO Pharma, L'Oréal, MEDahead, Moroscience, NACCME, Novartis, Omnicuris, P.G. Unna Academy, Sanofi, TouchIME, UCB, Vifor, and WebMD. Gil Yosipovitch has been a consultant and an advisor for Pfizer Inc., Arcutis, Bellus, Eli Lilly, Galderma, Kiniksa, LEO Pharma, Novartis, Pierre Fabre, Sanofi-Regeneron, Trevi Therapeutics, and a principal investigator for Pfizer Inc., Eli Lilly, Escient, Galderma, Kiniksa, LEO Pharma, Novartis, Pierre Fabre, and Sanofi-Regeneron. Thomas Luger has participated on advisory boards for Pfizer Inc., AbbVie, Amgen, Argenx, Celgene, Ceres Pharma, Eli Lilly, Galderma, Janssen, La Roche-Posay, LEO Pharma, Menlo Therapeutics, Mylan/Meda, Novartis, Pierre Fabre, PIQUR Therapeutics, Sandoz, Sanofi, and Symrise; acted as an investigator for Pfizer Inc., AbbVie, Celgene, Eli Lilly, Janssen, LEO Pharma, Menlo Therapeutics, Novartis, and Sandoz; participated as a speaker for Pfizer Inc., AbbVie, Galderma, Janssen, La Roche-Posay, Merck Sharp & Dohme, Mylan, Novartis, and Sanofi; and has received funding from Pfizer Inc., AbbVie, Celgene, Jansen-Cilag, Merck Sharp & Dohme, Mylan/Meda, Novartis, and Wolfe Laboratories. Brian Kim is a consultant and advisor for Pfizer Inc., AbbVie, Boehringer Ingelheim, Cara Therapeutics, Kiniksa, Menlo Therapeutics, and Sanofi-Regeneron; has received research grants from Cara Therapeutics, Celgene, and LEO Pharma; and is founder and stockholder in Nuogen Pharma. Brian Kim is currently affiliated with the Mark Lebwohl Center for Neuroinflammation and Sensation, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.